Ruane, Cunniff & Goldfarb’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-4,240
Closed -$528K 80
2017
Q1
$528K Sell
4,240
-998
-19% -$119K 0.01% 75
2016
Q4
$603K Sell
5,238
-475
-8% -$54.9K 0.01% 81
2016
Q3
$675K Sell
5,713
-7,220
-56% -$876K 0.01% 86
2016
Q2
$1.57M Sell
12,933
-992
-7% -$113K 0.01% 78
2016
Q1
$1.51M Sell
13,925
-50,828
-78% -$5.26M 0.01% 94
2015
Q4
$6.65M Sell
64,753
-11,647
-15% -$1.17M 0.04% 63
2015
Q3
$7.13M Sell
76,400
-957
-1% -$92.6K 0.04% 60
2015
Q2
$7.54M Buy
77,357
+1,420
+2% +$142K 0.04% 63
2015
Q1
$7.64M Sell
75,937
-9
-0% -$915 0.04% 61
2014
Q4
$7.94M Sell
75,946
-313
-0.4% -$33K 0.04% 65
2014
Q3
$8.13M Buy
76,259
+247
+0.3% +$25.6K 0.04% 63
2014
Q2
$7.95M Buy
76,012
+218
+0.3% +$22K 0.04% 65
2014
Q1
$7.45M Buy
75,794
+1,700
+2% +$158K 0.04% 62
2013
Q4
$6.79M Sell
74,094
-401
-0.5% -$37K 0.04% 63
2013
Q3
$6.46M Buy
74,495
+60,188
+421% +$5.4M 0.04% 66
2013
Q2
$1.23M Buy
+14,307
New +$1.21M 0.01% 94

Other funds holding JNJ

Ruane, Cunniff & Goldfarb's JNJ Position: Q2 2017 in Review

Ruane, Cunniff & Goldfarb sold out of Johnson & Johnson (JNJ) in Q2 2017, closing a stake of 4,240 shares — an estimated $528K sold.

Ruane, Cunniff & Goldfarb first reported a position in JNJ in Q2 2013 and held it in 16 quarters. The position peaked at $8.13M in Q3 2014. 2,349 funds tracked by Wall St. Rank hold JNJ as of Q2 2017.

  • Ruane, Cunniff & Goldfarb reported no remaining Johnson & Johnson position as of Q2 2017 after selling out during the quarter.
  • Ruane, Cunniff & Goldfarb sold 4,240 Johnson & Johnson shares in Q2 2017, an estimated $528K.
  • Ruane, Cunniff & Goldfarb first reported a position in Johnson & Johnson in Q2 2013 and held it in 16 quarters.
  • Ruane, Cunniff & Goldfarb's Johnson & Johnson position peaked at $8.13M in Q3 2014.
  • 2,349 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2017.

Based on Ruane, Cunniff & Goldfarb's 13F filing for Q2 2017, filed 14 Aug 2017.